Optibrium Company
Optibrium creates elegant software solutions for small molecule design, optimisation and data analysis.
Funding Status:
Private Equity
Industry:
Early Drug Development
Estimated Revenue:
$10M to $50M
Technology:
Software
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Total Funding:
1000000.0
Last Funding Date:
2022-06-21
Last Funding Type:
Private Equity
Employee Number:
11-50
Investors Number:
2.0
Founded Date:
2009-01-01